论文部分内容阅读
Introduction: The interaction between advanced glycation end-products (AGEs) and its receptors for AGEs (RAGEs) elicits oxidative stress and mediates the development of erectile dysfunction (ED).ALT-711, an AGE cross-link breaker, has the therapeutic potential for ED but has been less intensively investigated.Aim: The aim of this study was to investigate the effects of an AGEs breaker 3-phenacyl-4, 5-dimethylthiazolium chloride (ALT-711) plus insulin on erectile function in streptozocin (STZ)-induced type 1 diabetic rats.